HUM Humana Inc. Common Stock
About Humana Inc. Common Stock Company overview from Wikipedia
Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked company based in Kentucky. It is the fourth largest health insurance provider in the U.S.
Read more
Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked (by revenues) company based in Kentucky. It is the fourth largest health insurance provider in the U.S.
History
1961–1983: Nursing homes and hospitals
Lawyers David A. Jones Sr. and Wendell Cherry founded a nursing home company in 1961. The company, known in 1968 as Extendicare Inc., became the largest nursing home company in the United States. In 1972, Jones and Cherry sold the nursing home chain to purchase hospitals. Humana became one of the first two for-profit hospital ventures in the U.S. along with Hospital Corporation of America (HCA).
In 1974, the partners changed the corporate name to Humana Inc. The name was meant to change public perception from 'warehousing' or indifferently treating people to providing a higher level of human care and, by extension, more humane care. It grew in the following years, both by business and in 1978 through the takeover of American Medicorp Inc., which doubled the company's size, and grew into the world's largest hospital company in the 1980s. During this period, Humana developed the double corridor model for hospital construction. This design minimized the distance between patients and nurses by placing nursing support services in the interior of the building with patient rooms surrounding the perimeter.
1984–present
As the American health care system changed in the 1980s, "one of its hospitals in Arizona lost a contract with the largest health-maintenance organization in the area [and] Humana created its own health insurance plan."
In 1993, Humana had become the largest hospital operator in the country, owning 77 hospitals. Humana executives spun off hospital operations from health insurance operations to create Galen Health Care. The following year they sold the 73 hospitals of Galen Health Care Inc. to Nashville-based Columbia Hospital Corporation of America for $3.4 billion.
In 1998, one year after Jones had stepped aside as CEO, UnitedHealthcare made an unsuccessful attempt to acquire Humana. Humana pulled out of the acquisition after United stock dropped $2.9 billion in value. In 2001, Humana was a cofounder of Availity.
In 2005, Humana entered into a business partnership with Virgin Group, offering financial incentives to members for healthy behavior, such as regular exercise.
On November 16, 2006, the Centers for Disease Control and Prevention (CDC) and Humana Inc. partnered to expand on traditional private-sector approaches to population health management.
In 2010, Humana bought Texas-based Concentra Inc., which owns urgent-care and physical therapy centers, for $790 million, effectively returning to healthcare services. In May 2011, Humana announced it would be using mobileStorm to transmit protected health information to patients.
In March 2015, Humana announced the sale of Concentra to private equity firm Welsh, Carson, Anderson & Stowe and Select Medical Holdings Corporation for about $1 billion, with proceeds to fund a "$2 billion share buyback program and other corporate spending."
In July 2015, Aetna announced that it would acquire Humana for $37 billion in cash and stock (approximately $230 a share at that time). Aetna and Humana shareholders would own 74% and 26% of the new combined company. However, the U.S. Department of Justice's Antitrust Division alleged the acquisition would be anticompetitive and sued to block the transaction. Following a trial, U.S. district judge John D. Bates of the United States District Court for the District of Columbia agreed and issued an injunction blocking the acquisition. In February 2017, Aetna Inc. and Humana Inc. quashed a $34 billion merger agreement after judges ruled against the merger for a second time.
In July 2018, Humana joined two private equity firms in the acquisition of Kindred Healthcare. The deal provided Humana with a 40% stake in the company's home health, hospice and community care businesses, called "Kindred at Home," for approximately $800 million. In August 2018, Humana announced the creation of a digital health and analytics division called Humana Studio H.
In December 2019, the company announced it would acquire Enclara Healthcare from Consonance Capital Partners and Enclara management.
In 2021, Susan Diamond, formerly occupying an interim position, was announced to be the new permanent CFO. Her appointment to the position comes with the company's focus being turned towards the home healthcare business, acquiring in April of the same year a 60% stake in Kindred at Home, an in-home care and hospice business.
In April 2022, it was announced Humana would sell a 60% interest of its Kindred at Home division to the private investment company, Clayton, Dubilier & Rice, for US$2.8 billion.
In February 2023, Humana announced they were exiting the employer-based commercial group insurance market.
Corporate affairs
Sponsorship
Humana is the presenting sponsor of the Grand Ole Opry and the National Senior Games.
Since 1979, Humana has been a principal sponsor of the annual Humana Festival of New American Plays in Louisville, Kentucky.
Humana was a tour partner of the PGA Tour beginning from 2005 to 2015.
The Humana Distaff Handicap is a Grade 1 race for thoroughbred fillies and mares, four-years-old and up. The race is run each spring on Kentucky Derby day at Churchill Downs and set at a distance of 7 furlongs for a purse of $250,000.
Humana Military Healthcare Services
In 1993, Humana founded Humana Military Healthcare Services (HMHS) as a wholly owned subsidiary. They were awarded their first TRICARE contract in 1995, and began serving military beneficiaries in 1996.
From 2004 to 2009, HMHS was the managed care contractor for the Department of Defense Military Health System TRICARE South Region.
In 2009, HMHS' Managed Care Support Contract was awarded to United Military and Veterans Services, a subsidiary of UnitedHealth Group. HMHS protested that decision and the Government Accountability Office upheld the protest in late 2009.
In 2011, HMHS regained the five-year contract to administer medical benefits to military members and families in the South region, a contract worth $23.5 billion. In 2018, this was moved to the new TRICARE East region during the TRICARE regional realignment.
On December 22, 2022, the Department of Defense announced the award of the managed care support contract for the TRICARE East Region to Humana Military.
Legal campaign against drug price fixing
Humana filed a lawsuit in August 2019, alleging that 37 defendants engaged in a “far-reaching conspiracy” to “blatantly fix the price” of generic drugs. This follows a similar smaller lawsuit from October 2018.
Controversy
In 1987, Humana sued NBC over a story line in the television medical drama St. Elsewhere in which the hospital was to be sold to a for-profit medical corporation and renamed "Ecumena", with subsequent changes to the hospital, both positive and negative, emanating from that change. The company claimed that the program infringed on the Humana trademark. Humana failed to block the airing of the show, but was successful at forcing NBC into showing a disclaimer at the beginning of the September 30 episode saying that the drama had no connection whatsoever with Humana.
On May 30, 1996, Linda Peeno, a physician who was contracted to work for Humana for nine months, testified before Congress as to the downside of managed care. Peeno said she was effectively rewarded by her employer for causing the death of a patient, because it saved the company a half-million dollars. Peeno stated that she felt the "managed care" model was inherently unethical.
In 1999, season one of Michael Moore's TV series The Awful Truth reported on Humana refusing to pay for a diabetic patient with pancreatic failure needing a transplant. The man's policy stated it covered all of his diabetes-related expenses, but another section of the policy stated that it did not cover organ transplants. Moore conducted a fake funeral on the front steps of the Humana building, and three days later Humana changed its policy and authorized the man's treatment.
Michael Moore's 2007 documentary Sicko used the video of Linda Peeno's testimony. On June 28, 2007, Humana declared that Peeno was never a Humana "associate" (permanent, full-time employee), but rather a "part-time contractor." Humana disputed portions of her Congressional testimony by saying that because the patient's healthcare plan did not cover heart transplants, denial of coverage was valid.
On September 21, 2009, the U.S. Dept. of Health and Human Services opened an investigation into Humana for sending flyers to Medicare recipients that the AARP characterized as deceptive. The mail was made to appear to contain official information about Medicare Advantage and prescription drug benefit information, but instead alleged that core Medicare benefits could be cut by the Obama administration's healthcare reform, a claim refuted by John Rother, AARP's executive vice president. Douglas Elmendorf, the head of the Congressional Budget Office (CBO), supported the claim that Medicare benefits could be cut, but his comments were in reference to just one of several congressional bills. CBO estimates of another healthcare reform bill found that changes to premiums would vary. The Centers for Medicare and Medicaid Services instructed Humana to cease all such mailings to Medicare plan members pending an investigation. HHS Secretary Kathleen Sebelius, in a letter to the insurance industry, threatened that bad actors may be excluded from new health insurance markets that were to open in 2014. Senate Republicans pointed out in a letter to Sebelius that a 1997 directive from the Centers for Medicare and Medicaid Services explicitly allowed HMOs to tell members about legislation and urge them to express opinions.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
HUM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
HUM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Dividends Yield, payout ratio, dividend history, 5Y CAGR
| Ex-date | Amount |
|---|---|
| June 26, 2026 | $0.8850 |
| March 27, 2026 | $0.8850 |
| Dec. 26, 2025 | $0.8850 |
| Sept. 26, 2025 | $0.8850 |
| June 27, 2025 | $0.8850 |
| March 28, 2025 | $0.8850 |
| Dec. 31, 2024 | $0.8850 |
| Sept. 30, 2024 | $0.8850 |
| June 28, 2024 | $0.8850 |
| March 27, 2024 | $0.8850 |
| Dec. 28, 2023 | $0.8850 |
| Sept. 28, 2023 | $0.8850 |
| June 29, 2023 | $0.8850 |
| March 30, 2023 | $0.8850 |
| Dec. 29, 2022 | $0.7880 |
| Sept. 29, 2022 | $0.7880 |
| June 29, 2022 | $0.7880 |
| March 30, 2022 | $0.7880 |
| Dec. 30, 2021 | $0.7000 |
| Sept. 29, 2021 | $0.7000 |
HUM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 8 24.2%
- Buy 8 24.2%
- Hold 15 45.5%
- Sell 2 6.1%
- Strong Sell 0 0.0%
12-Month Price Target
23 analysts · 2026-08-19Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $7.61 | $7.29 | 0.32% |
| March 31, 2026 | $10.31 | $10.29 | 0.02% |
| Dec. 31, 2025 | $-3.96 | $-4.05 | 0.09% |
| Sept. 30, 2025 | $3.24 | $2.85 | 0.39% |
| June 30, 2025 | $6.27 | $5.98 | 0.29% |
| March 31, 2025 | $11.58 | $10.17 | 1.4% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | — |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | — |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | — |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | — |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| ALHC | $4.03B | — | 46.1% | -0.02% | -0.52% | — |
| CLOV | — | -5.1 | 40.3% | -4.5% | -26.2% | — |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 13
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| SG&A Expense | $15.45B | $13.70B | $13.19B | $12.67B | $10.12B | $10.05B | $7.38B | $7.53B | $6.57B | $7.17B | $7.29B | $7.64B | |
| Operating Income | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B | |
| Interest Expense | · | · | $493M | $401M | $326M | $283M | $242M | $218M | $242M | $189M | $186M | $192M | |
| Other Non-op | $-451M | $-181M | $-137M | $-68M | $532M | $-103M | $506M | $-33M | $0 | $0 | · | · | |
| Pretax Income | $1.44B | $1.62B | $3.33B | $3.57B | $3.42B | $4.67B | $3.47B | $2.07B | $4.02B | $1.55B | $2.43B | $2.17B | |
| Income Tax | $250M | $413M | $836M | $762M | $485M | $1.31B | $763M | $391M | $1.57B | $938M | $1.16B | $1.02B | |
| Net Income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| EPS (Basic) | $9.87 | $10.01 | $20.09 | $22.20 | $22.79 | $25.47 | $20.20 | $12.24 | $16.94 | $4.11 | $8.54 | $7.44 | |
| EPS (Diluted) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 | $8.44 | $7.36 | |
| Shares (Basic) | 120,454,000 | 120,571,000 | 123,866,000 | 126,419,000 | 128,688,000 | 132,199,000 | 134,055,000 | 137,486,000 | 144,493,000 | 149,375,000 | 149,455,000 | 154,187,000 | |
| Shares (Diluted) | 120,826,000 | 120,869,000 | 124,441,000 | 127,094,000 | 129,396,000 | 133,012,000 | 134,727,000 | 138,403,000 | 145,585,000 | 150,917,000 | 151,142,000 | 155,874,000 | |
| EBITDA | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B |
Balance Sheet 26
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.20B | $2.22B | $4.69B | $5.06B | $3.39B | $4.67B | $4.05B | $2.34B | $4.04B | $3.88B | $2.57B | $1.94B | |
| Short-term Investments | $15.70B | $18.21B | $16.63B | $13.88B | $13.19B | $12.55B | $10.97B | · | · | · | · | · | |
| Receivables | $3.27B | $2.70B | $2.04B | $1.67B | $1.81B | $1.14B | $1.06B | $1.01B | $854M | $1.28B | $1.16B | $1.05B | |
| Other Current Assets | $9.56B | $6.68B | $6.63B | $5.57B | $6.49B | $5.28B | $3.81B | $3.56B | $2.95B | $3.44B | $4.71B | $4.01B | |
| Current Assets | $32.73B | $29.82B | $29.99B | $26.18B | $24.89B | $23.64B | $19.89B | $16.95B | $17.40B | $16.19B | $15.71B | $15.54B | |
| PP&E (Net) | $2.23B | $2.53B | $3.03B | $3.22B | $3.07B | $2.37B | $1.96B | $1.74B | $1.58B | $1.50B | $1.38B | $1.23B | |
| PP&E (Gross) | $5.52B | $5.67B | $5.88B | $6.36B | $5.95B | $5.49B | $4.62B | $4.05B | $3.56B | $3.19B | $2.72B | $2.91B | |
| Accum. Depreciation | $3.29B | $3.14B | $2.85B | $3.14B | $2.87B | $3.12B | $2.66B | $2.31B | $1.98B | $1.69B | $1.34B | $1.68B | |
| Goodwill | $9.69B | $9.63B | $9.55B | $9.14B | $11.09B | $4.45B | $3.93B | $3.90B | $3.28B | $3.27B | $3.27B | $3.23B | |
| Intangibles | $1.13B | $1.44B | $1.69B | $1.76B | $2.64B | $329M | $177M | $245M | $226M | $280M | $357M | $440M | |
| Other Non-current Assets | $3.13B | $3.38B | $3.38B | $3.38B | $4.38B | $2.13B | $1.83B | $1.38B | $2.17B | $2.23B | $2.48B | $1.58B | |
| Total Assets | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Accounts Payable | $5.72B | $5.26B | $6.57B | $5.24B | $4.51B | $4.01B | $3.75B | $3.07B | $4.07B | $2.47B | $2.21B | $2.10B | |
| Short-term Debt | · | · | · | · | · | · | · | $1.69B | $150M | $300M | $299M | $0 | |
| Current Liabilities | $16.35B | $16.94B | $18.87B | $17.18B | $15.33B | $13.39B | $10.93B | $10.08B | $9.41B | $7.82B | $8.15B | $7.47B | |
| Capital Leases | $418M | $392M | $444M | $456M | $546M | $355M | $332M | · | · | · | · | · | |
| Other Non-current Liabilities | $2.46B | $1.95B | $1.66B | $1.47B | $2.38B | $1.79B | $1.14B | $581M | $237M | $263M | $235M | $236M | |
| Total Liabilities | $31.17B | $30.03B | $30.75B | $27.68B | $28.25B | $21.24B | $17.04B | $15.25B | $17.34B | $14.71B | $14.33B | $13.88B | |
| Total Debt | $12.37B | $11.14B | $10.21B | $9.03B | $10.54B | $6.06B | $4.97B | $6.07B | $4.92B | $4.09B | $4.12B | $3.83B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | |
| Retained Earnings | $29.07B | $28.32B | $27.54B | $25.49B | $23.09B | $20.52B | $17.48B | $15.07B | $13.67B | $11.45B | $11.02B | $9.92B | |
| Treasury Stock | $14.42B | $14.37B | $13.66B | $12.16B | $10.16B | $9.92B | $8.46B | $7.32B | $6.33B | $3.30B | $3.29B | $2.86B | |
| AOCI | $-633M | $-1.07B | $-999M | $-1.30B | $42M | $391M | $156M | $-159M | $19M | $-66M | $58M | $223M | |
| Stockholders' Equity | $17.66B | $16.38B | $16.26B | $15.31B | $16.08B | $13.73B | $12.04B | $10.16B | $9.84B | $10.69B | $10.35B | $9.65B | |
| Liabilities + Equity | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Shares Outstanding | 198,719,000 | 198,719,000 | 198,690,000 | 198,667,000 | 198,649,000 | 198,649,000 | 198,630,000 | · | · | · | · | · |
Cash Flow 17
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $698M | $839M | $779M | $709M | $596M | · | · | $444M | $410M | $388M | $354M | $328M | |
| Stock-based Comp | $241M | $207M | $175M | $216M | $180M | $181M | $163M | $137M | $157M | $115M | $109M | $98M | |
| Deferred Tax | $75M | $-192M | $-164M | $-100M | $15M | $195M | $162M | $194M | $132M | $-71M | $-2M | $-64M | |
| Amort. of Intangibles | $51M | $60M | $67M | $81M | $65M | $88M | $70M | $90M | $75M | $77M | $93M | $121M | |
| Restructuring | · | · | · | · | · | · | $47M | · | $148M | · | · | · | |
| Operating Cash Flow | $921M | $2.97B | $3.98B | $4.59B | $2.26B | $5.64B | $5.28B | $2.17B | $4.05B | $1.94B | $868M | $1.62B | |
| CapEx | $546M | $575M | $1.00B | $1.14B | $1.34B | $964M | $736M | $612M | $524M | $527M | $523M | $528M | |
| Investing Cash Flow | $2.27B | $-2.95B | $-3.49B | $-1.01B | $-6.56B | $-3.06B | $-1.28B | $-3.09B | $-2.94B | $-1.36B | $320M | $-63M | |
| Net Debt Issued | · | · | · | · | · | · | $-400M | $0 | $-800M | $0 | $0 | $-500M | |
| Stock Repurchased | $151M | $817M | $1.57B | $2.10B | $79M | $1.82B | $1.07B | $1.09B | $3.37B | $104M | $385M | $872M | |
| Net Stock Activity | $-151M | $-817M | $-1.57B | $-2.10B | $-79M | $-1.82B | $-1.07B | $-1.09B | $-3.37B | $-104M | $-385M | $-872M | |
| Dividends Paid | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M | |
| Financing Cash Flow | $-1.22B | $-2.49B | $-856M | $-1.91B | $3.02B | $-1.96B | $-2.29B | $-785M | $-945M | $732M | $-552M | $-758M | |
| Net Change in Cash | $1.98B | $-2.47B | $-367M | $1.67B | $-1.28B | $619M | $1.71B | $-1.70B | $165M | $1.31B | $636M | $797M | |
| Taxes Paid | · | $570M | $997M | $758M | $227M | $1.13B | $518M | $631M | $1.50B | $916M | $1.18B | $1.03B | |
| Free Cash Flow | $375M | $2.39B | $2.98B | $3.47B | $946M | $4.67B | $4.55B | $1.56B | $3.52B | $1.41B | $345M | $1.09B | |
| Levered FCF | · | · | $2.61B | $3.15B | $666M | $4.47B | $4.36B | $1.38B | $3.38B | $1.33B | $247M | $989M |
Profitability 7
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| Net Margin | 0.92% | 1.0% | 2.3% | 3.0% | 3.5% | 4.4% | 4.2% | 3.0% | 4.5% | 1.1% | 2.4% | 2.4% | |
| Pretax Margin | 1.1% | 1.5% | 3.1% | 3.8% | 4.1% | 6.1% | 5.3% | 3.6% | 7.5% | 2.9% | 4.5% | 4.5% | |
| EBITDA Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| ROA | 2.5% | 2.6% | 5.5% | 6.4% | 7.4% | 10.5% | 9.9% | 6.4% | 9.3% | 2.5% | 5.3% | 5.2% | |
| ROE | 7.0% | 7.4% | 15.8% | 18.2% | 18.1% | 22.8% | 22.9% | 16.2% | 23.3% | 5.8% | 12.8% | 12.1% | |
| ROIC | 7.4% | 7.1% | 11.3% | 12.3% | 10.1% | 18.1% | 14.6% | 15.5% | 17.6% | 4.7% | 8.5% | 9.3% |
Liquidity & Solvency 5
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 | 1.8 | 1.8 | 1.7 | 1.9 | 2.1 | 1.9 | 2.0 | |
| Quick Ratio | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 | 1.4 | 0.5 | 0.3 | 0.5 | 0.7 | 0.5 | 0.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.6 | 0.5 | 0.4 | 0.4 | 0.4 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | |
| Interest Coverage | · | · | 8.1 | 9.5 | 9.7 | 17.6 | 13.2 | 14.2 | 17.6 | 9.2 | 12.6 | 12.3 |
Efficiency 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.7 | 2.5 | 2.4 | 2.1 | 2.1 | 2.4 | 2.4 | 2.2 | 2.0 | 2.2 | 2.3 | 2.2 | |
| Receivables Turnover | 43.4 | 49.7 | 57.4 | 53.3 | 56.3 | 70.3 | 62.7 | 60.9 | 50.4 | 44.6 | 49.0 | 45.8 |
Growth Rates 10
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 10.7% | 14.5% | 11.8% | 7.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.8% | 12.3% | 11.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.4% | -50.1% | -9.4% | -2.6% | -10.4% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -23.6% | -23.9% | -7.5% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -17.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -1.6% | -51.5% | -11.3% | -4.3% | -12.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -24.9% | -25.6% | -9.6% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -18.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 5.9% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM) 17
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| Net Income TTM | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| Market Cap | $50.90B | $50.42B | $90.96B | $101.76B | · | · | · | · | · | · | · | · | |
| Enterprise Value | $43.36B | $41.13B | $79.86B | $91.85B | · | · | · | · | · | · | · | · | |
| P/E | 26.0 | 25.4 | 22.9 | 23.2 | 20.5 | 16.2 | 18.2 | 23.6 | 14.8 | 50.1 | 21.2 | 19.5 | |
| P/S | 0.4 | 0.4 | 0.9 | 1.1 | · | · | · | · | · | · | · | · | |
| P/B | 2.9 | 3.1 | 5.6 | 6.6 | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 7.4 | 9.5 | 18.1 | 23.1 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 55.3 | 17.0 | 22.8 | 22.2 | · | · | · | · | · | · | · | · | |
| P / FCF | 135.7 | 21.1 | 30.6 | 29.3 | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 16.0 | 16.1 | 19.9 | 24.2 | · | · | · | · | · | · | · | · | |
| EV / FCF | 115.6 | 17.2 | 26.8 | 26.5 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 0.3 | 0.3 | 0.8 | 1.0 | · | · | · | · | · | · | · | · | |
| Dividend Yield | 0.84% | 0.85% | 0.47% | 0.39% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.8% | 3.9% | 4.4% | 4.3% | 4.9% | 6.2% | 5.5% | 4.2% | 6.8% | 2.0% | 4.7% | 5.1% | |
| Payout Ratio | 36.2% | 35.7% | 17.3% | 14.0% | 12.1% | 9.6% | 10.8% | 15.8% | 9.0% | 28.8% | 13.5% | 15.0% | |
| Annual Payout | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M |
Income Statement 13
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.87B | $39.65B | $32.52B | $32.65B | $32.39B | $32.11B | $29.21B | $29.40B | $29.54B | $29.61B | $26.46B | $26.42B | $26.75B | $26.74B | $22.44B | $22.80B | |
| SG&A Expense | $3.98B | $4.02B | $4.44B | $4.08B | $3.55B | $3.38B | $4.17B | $3.34B | $3.15B | $3.04B | $3.83B | $3.27B | $3.11B | $2.98B | $3.55B | $3.06B | |
| Operating Income | $1.36B | $1.75B | $-808M | $400M | $1.10B | $2.01B | $-543M | $728M | $1.14B | $1.24B | $-348M | $1.21B | $1.44B | $1.72B | $124M | $1.17B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $159M | · | $114M | $120M | $113M | · | $102M | |
| Other Non-op | $-211M | $34M | $-53M | $-35M | $-200M | $-163M | $-155M | $92M | $-55M | $-63M | $-97M | $6M | $-54M | $8M | $-84M | $-13M | |
| Pretax Income | $952M | $1.59B | $-1.13B | $134M | $741M | $1.69B | $-963M | $651M | $918M | $1.01B | $-610M | $1.09B | $1.25B | $1.60B | $-72M | $1.30B | |
| Income Tax | $238M | $395M | $-249M | $-86M | $179M | $406M | $-216M | $155M | $223M | $251M | $-75M | $256M | $296M | $359M | $-58M | $107M | |
| Net Income | $694M | $1.19B | $-796M | $195M | $545M | $1.24B | $-693M | $480M | $679M | $741M | $-541M | $832M | $959M | $1.24B | $-15M | $1.20B | |
| EPS (Basic) | $5.78 | $9.85 | $-6.58 | $1.62 | $4.52 | $10.31 | $-5.74 | $3.99 | $5.63 | $6.13 | $-4.26 | $6.74 | $7.70 | $9.91 | $-0.07 | $9.45 | |
| EPS (Diluted) | $5.73 | $9.83 | $-6.59 | $1.62 | $4.51 | $10.30 | $-5.73 | $3.98 | $5.62 | $6.11 | $-4.24 | $6.71 | $7.66 | $9.87 | $-0.08 | $9.39 | |
| Shares (Basic) | 120,066,000 | 120,332,000 | -241,024,000 | 120,273,000 | 120,539,000 | 120,666,000 | -241,257,000 | 120,405,000 | 120,445,000 | 120,978,000 | -249,139,000 | 123,426,000 | 124,574,000 | 125,005,000 | -253,614,000 | 126,572,000 | |
| Shares (Diluted) | 121,135,000 | 120,652,000 | -241,508,000 | 120,745,000 | 120,745,000 | 120,844,000 | -241,828,000 | 120,764,000 | 120,665,000 | 121,268,000 | -250,215,000 | 123,983,000 | 125,109,000 | 125,564,000 | -254,820,000 | 127,356,000 | |
| EBITDA | $1.36B | $1.75B | · | $400M | $1.10B | $2.01B | · | $728M | $1.14B | $1.24B | · | $1.21B | $1.44B | $1.72B | · | $1.17B |
Balance Sheet 25
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.89B | $4.95B | $4.20B | $5.39B | $4.04B | $4.25B | $2.22B | $5.12B | $5.50B | $5.91B | · | $15.15B | $16.21B | $13.73B | · | $13.56B | |
| Short-term Investments | $16.98B | $17.01B | $15.70B | $16.74B | $17.67B | $17.89B | $18.21B | $19.03B | $17.42B | $16.70B | · | $15.14B | $15.25B | $14.93B | · | $13.12B | |
| Receivables | $5.70B | $5.22B | $3.27B | $2.68B | $4.50B | $4.46B | $2.70B | $2.14B | $4.09B | $3.92B | · | $1.82B | $1.43B | $3.11B | · | $1.61B | |
| Other Current Assets | $10.52B | $10.90B | $9.56B | $7.94B | $7.40B | $7.83B | $6.68B | $6.63B | $5.84B | $6.26B | · | $6.14B | $5.87B | $5.76B | · | $5.42B | |
| Current Assets | $40.09B | $38.08B | $32.73B | $32.75B | $33.62B | $34.42B | $29.82B | $32.93B | $32.86B | $32.80B | · | $38.25B | $38.76B | $37.53B | · | $33.71B | |
| PP&E (Net) | $2.10B | $2.17B | $2.23B | $2.27B | $2.36B | $2.43B | $2.53B | $2.69B | $2.82B | $2.98B | · | $3.34B | $3.31B | $3.23B | · | $3.22B | |
| PP&E (Gross) | · | · | $5.52B | · | · | · | $5.67B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3.29B | · | · | · | $3.14B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $10.48B | $10.49B | $9.69B | $9.62B | $9.63B | $9.63B | $9.63B | $9.59B | $9.57B | $9.56B | $9.55B | $9.54B | $9.54B | $9.32B | $9.14B | $9.10B | |
| Intangibles | $1.18B | $1.19B | $1.13B | $1.23B | $1.38B | $1.43B | $1.44B | $1.65B | $1.66B | $1.68B | · | $1.76B | $1.78B | $1.75B | · | $1.80B | |
| Other Non-current Assets | $3.25B | $3.28B | $3.13B | $4.02B | $3.69B | $3.38B | $3.38B | $3.67B | $3.72B | $3.64B | · | $3.64B | $3.73B | $3.58B | · | $3.63B | |
| Total Assets | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Accounts Payable | $7.26B | $6.53B | $5.72B | $5.52B | $5.59B | $5.38B | $5.26B | $5.92B | $6.53B | $6.50B | · | $7.60B | $8.12B | $7.43B | · | $6.77B | |
| Current Liabilities | $23.01B | $21.51B | $16.35B | $16.18B | $17.22B | $18.04B | $16.94B | $18.73B | $19.79B | $19.69B | · | $27.82B | $28.28B | $26.94B | · | $25.05B | |
| Capital Leases | · | · | $418M | · | · | · | $392M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2.93B | $2.85B | $2.46B | $2.35B | $2.26B | $2.34B | $1.95B | $1.77B | $1.83B | $1.83B | · | $1.59B | $1.56B | $1.46B | · | $1.60B | |
| Total Liabilities | $37.92B | $36.63B | $31.17B | $31.14B | $32.06B | $33.11B | $30.03B | $32.38B | $33.37B | $33.91B | · | $38.90B | $39.56B | $38.14B | · | $34.45B | |
| Total Debt | $11.98B | $12.27B | · | $12.61B | $12.59B | $12.73B | · | $11.89B | $11.75B | $12.39B | · | $9.48B | $9.72B | $9.74B | · | $7.80B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | · | $33M | $33M | $33M | · | $33M | |
| Retained Earnings | $30.74B | $30.15B | $29.07B | $29.98B | $29.89B | $29.45B | $28.32B | $29.12B | $28.75B | $28.17B | · | $28.19B | $27.47B | $26.62B | · | $25.61B | |
| Treasury Stock | $14.51B | $14.52B | $14.42B | $14.46B | $14.46B | $14.36B | $14.37B | $14.40B | $14.40B | $14.36B | · | $13.13B | $12.75B | $12.22B | · | $11.15B | |
| AOCI | $-751M | $-731M | $-633M | $-666M | $-783M | $-868M | $-1.07B | $-653M | $-1.12B | $-1.09B | · | $-1.50B | $-1.23B | $-1.11B | · | $-1.47B | |
| Stockholders' Equity | $19.21B | $18.58B | $17.66B | $18.52B | $18.23B | $17.75B | $16.38B | $17.57B | $16.67B | $16.13B | · | $16.95B | $16.83B | $16.58B | · | $16.32B | |
| Liabilities + Equity | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Shares Outstanding | 198,720,000 | 198,720,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,691,000 | 198,690,000 | 198,690,000 | 198,690,000 | 198,667,000 | 198,667,000 | 198,667,000 |
Cash Flow 17
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $159M | $163M | $164M | $173M | $178M | $183M | $208M | $210M | $212M | $209M | $201M | $201M | $191M | $186M | · | · | |
| Stock-based Comp | $65M | $51M | $48M | $83M | $61M | $49M | $54M | $53M | $55M | $45M | $33M | $53M | $51M | $38M | $43M | $80M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $-164M | $0 | · | · | $-67M | $-200M | |
| Amort. of Intangibles | $8M | $11M | $8M | $13M | $15M | $15M | $14M | $15M | $15M | $16M | $16M | $17M | $16M | $18M | $20M | $25M | |
| Operating Cash Flow | $1.97B | $1.25B | $-1.65B | $971M | $1.27B | $331M | $-528M | $1.86B | $1.21B | $423M | $-7.13B | $1.25B | $3.18B | $6.69B | $-5.13B | $8.45B | |
| CapEx | $132M | $121M | $202M | $135M | $114M | $95M | $154M | $130M | $114M | $177M | $283M | $234M | $264M | $223M | $275M | $288M | |
| Investing Cash Flow | $-273M | $-2.55B | $632M | $980M | $347M | $314M | $-63M | $-1.47B | $-1.00B | $-414M | $-882M | $-585M | $-733M | $-1.29B | $-1.01B | $1.68B | |
| Debt Issued | $0 | $990M | · | · | $0 | $1.48B | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | $980M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $1M | $107M | $42M | $0 | $100M | $9M | $49M | $2M | $49M | $717M | $571M | $379M | $529M | $94M | $1.06B | $4M | |
| Net Stock Activity | · | $-107M | · | · | · | $-9M | · | · | · | $-717M | · | · | · | $-94M | · | · | |
| Dividends Paid | $107M | $107M | $109M | $107M | $106M | $108M | $108M | $107M | $107M | $109M | $111M | $109M | $111M | $100M | $101M | $100M | |
| Financing Cash Flow | $249M | $2.05B | $-168M | $-603M | $-1.83B | $1.38B | $-2.30B | $-770M | $-620M | $1.21B | $-2.44B | $-1.73B | $36M | $3.28B | $-2.36B | $-1.79B | |
| Net Change in Cash | $1.94B | $751M | $-1.19B | $1.35B | $-210M | $2.03B | $-2.90B | $-385M | $-409M | $1.22B | $-10.45B | $-1.07B | $2.48B | $8.67B | $-8.50B | $8.34B | |
| Taxes Paid | $148M | $-7M | · | $122M | $41M | $-12M | · | $208M | $361M | $1M | · | $276M | $675M | $6M | $7M | $378M | |
| Free Cash Flow | · | $1.13B | · | · | · | $236M | · | · | · | $246M | · | · | · | $6.46B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $127M | · | · | · | $6.38B | · | · |
Profitability 7
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| Net Margin | 1.7% | 3.0% | · | 0.60% | 1.7% | 3.9% | · | 1.6% | 2.3% | 2.5% | · | 3.1% | 3.6% | 4.6% | · | 5.2% | |
| Pretax Margin | 2.3% | 4.0% | · | 0.41% | 2.3% | 5.3% | · | 2.2% | 3.0% | 3.3% | · | 4.1% | 4.7% | 6.0% | · | 5.7% | |
| EBITDA Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| ROA | 1.3% | 2.2% | · | 0.39% | 1.1% | 2.5% | · | 0.91% | 1.3% | 1.4% | · | 1.6% | 1.9% | 2.5% | · | 2.5% | |
| ROE | 3.7% | 6.5% | · | 1.1% | 3.1% | 7.3% | · | 2.8% | 4.0% | 4.5% | · | 5.0% | 5.9% | 7.8% | · | 7.3% | |
| ROIC | 3.3% | 4.3% | · | 2.1% | 2.7% | 5.0% | · | 1.9% | 3.0% | 3.2% | · | 3.5% | 4.1% | 5.1% | · | 4.5% |
Liquidity & Solvency 5
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.8 | · | 2.0 | 2.0 | 1.9 | · | 1.8 | 1.7 | 1.7 | · | 1.4 | 1.4 | 1.4 | · | 1.3 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | 1.4 | 1.3 | · | 1.2 | 1.2 | 1.2 | · | 1.1 | |
| Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| LT Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 7.8 | · | 10.6 | 12.0 | 15.2 | · | 11.5 |
Efficiency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | |
| Receivables Turnover | 8.0 | 8.2 | · | 13.5 | 7.5 | 7.7 | · | 14.8 | 10.7 | 8.4 | · | 15.4 | 11.1 | 8.5 | · | 13.1 |
Valuation (TTM) 15
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $145.55B | $136.80B | · | $126.55B | $123.44B | $120.66B | · | $114.97B | $112.32B | $109.52B | · | $102.71B | $99.95B | $97.17B | · | $91.13B | |
| Net Income TTM | $2.62B | $3.17B | · | $2.46B | $2.95B | $3.14B | · | $2.73B | $3.21B | $3.77B | · | $4.22B | $4.09B | $4.06B | · | $4.35B | |
| Market Cap | $78.94B | $34.46B | · | $51.70B | $48.58B | $52.58B | · | $62.94B | $74.25B | $68.89B | · | $96.67B | $88.84B | $96.44B | · | $96.39B | |
| Enterprise Value | $67.04B | $24.77B | · | $42.18B | $39.46B | $43.17B | · | $50.68B | $63.07B | $58.67B | · | $75.86B | $67.10B | $77.52B | · | $77.51B | |
| P/E | 18.3 | 6.6 | · | 12.7 | 10.0 | 10.2 | · | 14.1 | 14.3 | 11.4 | · | 14.5 | 13.8 | 15.2 | · | 14.3 | |
| P/S | 0.5 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.7 | 0.6 | · | 0.9 | 0.9 | 1.0 | · | 1.1 | |
| P/B | 4.1 | 1.9 | · | 2.8 | 2.7 | 3.0 | · | 3.6 | 4.5 | 4.3 | · | 5.7 | 5.3 | 5.8 | · | 5.9 | |
| P / Tangible Book | 10.5 | 5.0 | · | 6.7 | 6.7 | 7.9 | · | 10.0 | 13.6 | 14.1 | · | 17.1 | 16.1 | 17.5 | · | 17.8 | |
| P / Cash Flow | · | 27.5 | · | · | · | 158.9 | · | · | · | 162.9 | · | · | · | 14.4 | · | · | |
| P / FCF | · | 30.4 | · | · | · | 222.8 | · | · | · | 280.0 | · | · | · | 14.9 | · | · | |
| EV / EBITDA | 49.3 | 14.1 | · | 105.5 | 35.9 | 21.4 | · | 69.6 | 55.3 | 47.5 | · | 62.9 | 46.7 | 45.1 | · | 66.1 | |
| EV / FCF | · | 21.9 | · | · | · | 182.9 | · | · | · | 238.5 | · | · | · | 12.0 | · | · | |
| EV / Revenue | 0.5 | 0.2 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.6 | 0.5 | · | 0.7 | 0.7 | 0.8 | · | 0.9 | |
| Earnings Yield | 5.5% | 15.2% | · | 7.8% | 10.0% | 9.8% | · | 7.1% | 7.0% | 8.8% | · | 6.9% | 7.2% | 6.6% | · | 7.0% | |
| Payout Ratio | · | 9.0% | · | · | · | 8.7% | · | · | · | 14.7% | · | · | · | 8.1% | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B |
| Operating Margin % | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% |
| Net Income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B |
| Diluted EPS | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 |
| Current Ratio | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 |
| Quick Ratio | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $375M | $2.39B | $2.98B | $3.47B | $946M |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 1,050 filers · $33.7B total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 255 (+136 vs prior Q) | 83 (-77 vs prior Q) | 316 (+44 vs prior Q) | 274 (-45 vs prior Q) | +8.8M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Dodge & Cox | $4,345,737,744 | 10,940,380 | 12.89% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $3,115,642,737 | 7,843,620 | 9.24% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,311,405,702 | 5,818,956 | 6.86% | Shares |
| STATE STREET CORP | $2,172,441,313 | 5,457,072 | 6.45% | Shares |
| EAGLE CAPITAL MANAGEMENT LLC | $1,528,010,749 | 3,846,762 | 4.53% | Shares |
| Sessa Capital IM, L.P. | $1,480,732,883 | 3,727,740 | 4.39% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $1,181,074,714 | 2,976,242 | 3.50% | Shares |
| Capital International Investors | $950,462,637 | 2,392,826 | 2.82% | Shares |
| NAYA CAPITAL MANAGEMENT UK LTD | $728,407,339 | 1,833,763 | 2.16% | Shares |
| NORGES BANK | $694,505,009 | 1,748,414 | 2.06% | Shares |
| GOLDMAN SACHS GROUP INC | $659,096,868 | 1,659,274 | 1.96% | Shares |
| FMR LLC | $615,633,048 | 1,549,854 | 1.83% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $544,502,820 | 1,370,784 | 1.62% | Shares |
| Capital Research Global Investors | $443,462,035 | 1,116,990 | 1.32% | Shares |
| Slate Path Capital LP | $428,969,795 | 1,079,930 | 1.27% | Shares |
| Capital World Investors | $406,119,738 | 1,022,425 | 1.21% | Shares |
| Newport Trust Company, LLC | $384,768,345 | 968,653 | 1.14% | Shares |
| CITADEL ADVISORS LLC | $363,376,856 | 914,800 | 1.08% | Call option |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $348,908,912 | 878,377 | 1.04% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $331,490,508 | 834,526 | 0.98% | Shares |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $314,921,577 | 792,814 | 0.93% | Shares |
| CITADEL ADVISORS LLC | $310,904,094 | 782,700 | 0.92% | Put option |
| WELLINGTON MANAGEMENT GROUP LLP | $282,117,958 | 710,231 | 0.84% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $267,791,027 | 674,163 | 0.79% | Shares |
| Maple Rock Capital Partners Inc. | $249,553,862 | 628,251 | 0.74% | Shares |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $245,555,446 | 618,185 | 0.73% | Shares |
| GOLDMAN SACHS GROUP INC | $232,333,978 | 584,900 | 0.69% | Call option |
| MARSHALL WACE, LLP | $216,873,381 | 545,978 | 0.64% | Shares |
| CITADEL ADVISORS LLC | $178,080,082 | 448,316 | 0.53% | Shares |
| High Ground Investment Management LLP | $177,941,848 | 447,968 | 0.53% | Shares |
| 1832 Asset Management L.P. | $176,401,430 | 444,090 | 0.52% | Shares |
| BCV Asset Management Inc. | $173,695,656 | 445,719 | 0.52% | Shares |
| BANK OF AMERICA CORP /DE/ | $172,703,708 | 434,781 | 0.51% | Shares |
| Holocene Advisors, LP | $165,040,541 | 415,489 | 0.49% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $147,490,964 | 371,308 | 0.44% | Shares |
| MILLENNIUM MANAGEMENT LLC | $140,098,700 | 352,698 | 0.42% | Shares |
| JANE STREET GROUP, LLC | $137,080,622 | 345,100 | 0.41% | Call option |
| Swiss National Bank | $134,522,525 | 338,660 | 0.40% | Shares |
| JANE STREET GROUP, LLC | $122,542,370 | 308,500 | 0.36% | Put option |
| STEADFAST CAPITAL MANAGEMENT LP | $122,423,204 | 308,200 | 0.36% | Shares |
| BlackRock, Inc. | $120,890,332 | 304,341 | 0.36% | Shares |
| Mitsubishi UFJ Asset Management Co., Ltd. | $115,565,201 | 290,935 | 0.34% | Shares |
| VANGUARD ASSET MANAGEMENT, Ltd | $109,135,401 | 274,748 | 0.32% | Shares |
| AMERIPRISE FINANCIAL INC | $108,302,217 | 272,614 | 0.32% | Shares |
| Legal & General Group Plc | $103,424,967 | 260,372 | 0.31% | Shares |
| Vanguard Global Advisers, LLC | $103,330,825 | 260,135 | 0.31% | Shares |
| GOLDMAN SACHS GROUP INC | $103,078,590 | 259,500 | 0.31% | Put option |
| NEUBERGER BERMAN GROUP LLC | $102,585,352 | 258,258 | 0.30% | Shares |
| BANK OF NOVA SCOTIA | $102,313,941 | 257,575 | 0.30% | Shares |
| RHUMBLINE ADVISERS | $102,294,748 | 257,527 | 0.30% | Shares |
| Sumitomo Mitsui Trust Group, Inc. | $101,464,685 | 255,437 | 0.30% | Shares |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $100,979,680 | 254,216 | 0.30% | Shares |
| Gotham Asset Management, LLC | $89,318,889 | 224,860 | 0.27% | Shares |
| Balyasny Asset Management L.P. | $87,965,958 | 221,454 | 0.26% | Shares |
| FIRST TRUST ADVISORS LP | $85,094,587 | 214,226 | 0.25% | Shares |
| Ensign Peak Advisors, Inc | $83,532,585 | 210,293 | 0.25% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $83,463,866 | 210,120 | 0.25% | Shares |
| Brandywine Global Investment Management, LLC | $80,388,706 | 313,859 | 0.24% | Shares |
| California Public Employees Retirement System | $80,274,587 | 202,091 | 0.24% | Shares |
| WOLVERINE TRADING, LLC | $76,135,109 | 298,300 | 0.23% | Call option |
| Camber Capital Management LP | $73,344,000 | 300,000 | 0.22% | Shares |
| National Pension Service | $70,860,473 | 178,391 | 0.21% | Shares |
| BARCLAYS PLC | $70,472,788 | 177,415 | 0.21% | Shares |
| Susquehanna Portfolio Strategies, LLC | $69,949,250 | 176,097 | 0.21% | Shares |
| Walleye Trading LLC | $69,473,778 | 174,900 | 0.21% | Call option |
| CANADA PENSION PLAN INVESTMENT BOARD | $68,018,761 | 171,237 | 0.20% | Shares |
| ARGA Investment Management, LP | $66,165,730 | 166,572 | 0.20% | Shares |
| ORBIMED ADVISORS LLC | $65,183,802 | 164,100 | 0.19% | Shares |
| Solel Partners LP | $64,742,888 | 162,990 | 0.19% | Shares |
| AMF Tjanstepension AB | $61,961,951 | 155,989 | 0.18% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $60,794,124 | 153,049 | 0.18% | Shares |
| Perpetual Ltd | $57,945,659 | 145,878 | 0.17% | Shares |
| CI INVESTMENTS INC. | $57,302,560 | 144,259 | 0.17% | Shares |
| AMERICAN CENTURY COMPANIES INC | $56,575,256 | 142,426 | 0.17% | Shares |
| Squarepoint Ops LLC | $56,047,742 | 141,100 | 0.17% | Put option |
| Aberdeen Group plc | $53,345,852 | 134,298 | 0.16% | Shares |
| WOLVERINE TRADING, LLC | $52,653,949 | 206,300 | 0.16% | Put option |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $52,178,000 | 131,358 | 0.15% | Shares |
| ING GROEP NV | $51,583,784 | 129,862 | 0.15% | Shares |
| Squarepoint Ops LLC | $50,685,272 | 127,600 | 0.15% | Call option |
| Walleye Trading LLC | $49,573,056 | 124,800 | 0.15% | Put option |
| D. E. Shaw & Co., Inc. | $46,514,462 | 117,100 | 0.14% | Call option |
| BRAIDWELL LP | $45,481,690 | 114,500 | 0.13% | Shares |
| Jain Global LLC | $43,694,200 | 110,000 | 0.13% | Put option |
| BANK OF MONTREAL /CAN/ | $43,207,208 | 108,774 | 0.13% | Shares |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $42,190,325 | 106,214 | 0.13% | Shares |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $42,127,167 | 106,055 | 0.12% | Shares |
| AVIVA PLC | $41,509,093 | 104,499 | 0.12% | Shares |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $41,468,472 | 161,904 | 0.12% | Shares |
| ROYAL BANK OF CANADA | $41,033,000 | 103,301 | 0.12% | Shares |
| Pentwater Capital Management LP | $39,722,000 | 100,000 | 0.12% | Call option |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $39,284,661 | 98,899 | 0.12% | Shares |
| Point72 Asset Management, L.P. | $39,122,595 | 98,491 | 0.12% | Shares |
| PFM Health Sciences, LP | $37,487,638 | 94,375 | 0.11% | Shares |
| Summit Street Capital Management, LLC | $36,325,372 | 91,449 | 0.11% | Shares |
| Columbus Hill Capital Management, L.P. | $35,501,935 | 89,376 | 0.11% | Shares |
| Korea Investment CORP | $34,579,193 | 87,053 | 0.10% | Shares |
| Quantinno Capital Management LP | $32,817,091 | 82,616 | 0.10% | Shares |
| Fisher Funds Management LTD | $32,811,563 | 82,603 | 0.10% | Shares |
| Swedbank AB | $32,034,603 | 80,647 | 0.10% | Shares |
Company insiders 76 insiders · 46 officers · 27 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| James A. Rechtin | President & CEO | May 14, 2025 P | 30,474 | 0 | 0 | $0 |
| Bruce D Broussard | Chief Executive Officer | Feb. 21, 2024 A | 110,130 | 0 | 0 | $0 |
| Celeste Mellet | Chief Financial Officer | Feb. 24, 2025 A | 29,676 | 0 | 0 | $0 |
| Susan M Diamond | Chief Financial Officer | Dec. 31, 2024 J | 20,165 | 0 | 0 | $0 |
| Brian A Kane | Chief Financial Officer | Feb. 22, 2021 A | 24,342 | 0 | 0 | $0 |
| Steven E Mcculley | Interim CFO & Treasurer | May 9, 2014 G | 14,916 | 0 | 0 | $0 |
| George Renaudin II | President, Insurance | March 27, 2025 J | 15,702 | 0 | 0 | $0 |
| David Dintenfass | President, Enterprise Growth | Feb. 24, 2025 A | 16,234 | 0 | 0 | $0 |
| Sanjay K Shetty | President, CenterWell | Feb. 24, 2025 A | 11,566 | 0 | 0 | $0 |
| M.D. Andrew C. Agwunobi, | Seg. President, Home Solutions | Feb. 24, 2023 A | 182 | 0 | 0 | $0 |
| Timothy Alan Wheatley | Segment President, Retail | Dec. 15, 2022 M | 3,983 | 0 | 0 | $0 |
| Joseph William Jasser | Seg. President, Care Delivery | Dec. 15, 2017 M | 222 | 0 | 0 | $0 |
| Thomas J Liston | President - Retail Segment | Feb. 18, 2014 A | 105,443 | 0 | 0 | $0 |
| James E Murray | EVP & COO | March 31, 2017 J | 34,668 | 0 | 0 | $0 |
| Japan Mehta | Chief Information Officer | Feb. 24, 2025 A | 8,628 | 0 | 0 | $0 |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Feb. 24, 2025 A | 1,767 | 0 | 0 | $0 |
| Michelle A. O'Hara | Chief Human Resources Officer | Feb. 24, 2025 A | 11,266 | 0 | 0 | $0 |
| Joseph C Ventura | Chief Legal Officer | Feb. 24, 2025 A | 17,267 | 0 | 0 | $0 |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Feb. 24, 2025 A | 16,717 | 0 | 0 | $0 |
| Timothy S. Huval | Chief Administrative Officer | Dec. 31, 2024 G | 7,111 | 0 | 0 | $0 |
| Samir Deshpande | Chief Information Officer | Dec. 15, 2024 M | 14,015 | 0 | 0 | $0 |
| William Kevin Fleming | Chief Corporate Aff. Officer | Feb. 21, 2024 A | 11,723 | 0 | 0 | $0 |
| Susan D. Schick | Seg Pres. Grp. & Military Bus. | Feb. 24, 2023 F | 3,687 | 0 | 0 | $0 |
| William H Shrank | Chief Medical Officer | May 1, 2022 M | 4,294 | 0 | 0 | $0 |
| Cynthia H Zipperle | SVP, Chief Acct Officer & Cont | March 22, 2022 J | 5,723 | 0 | 0 | $0 |
| Heather Cox | Chief Dig Health & Analyt Off. | Feb. 25, 2022 F | 6,014 | 0 | 0 | $0 |
| Christopher H. Hunter | Seg Pres. Gr. & Military Bus. | March 16, 2021 G | 8,168 | 0 | 0 | $0 |
| Elizabeth D Bierbower | Strategic Advisor | Dec. 18, 2019 M | 18,092 | 0 | 0 | $0 |
| Brian P. Leclaire | Strategic Advisor | Dec. 15, 2019 M | 6,339 | 0 | 0 | $0 |
| Jody L Bilney | Chief Consumer Officer | Feb. 25, 2019 A | 9,774 | 0 | 0 | $0 |
| Roy A Beveridge, | Chief Medical Officer | Feb. 19, 2019 M | 10,791 | 0 | 0 | $0 |
| Todoroff M Christopher | Chief Legal Officer | Dec. 15, 2018 M | 11,136 | 0 | 0 | $0 |
| Heidi S Margulis | Chief Corp. Affairs Officer | Dec. 15, 2018 M | 6,476 | 0 | 0 | $0 |
| Christopher E Kay | SVP & Chief Innovation Officer | March 17, 2017 M | 4,361 | 0 | 0 | $0 |
| Tim S Mcclain | Group Pres, Govt & Other Busin | Feb. 18, 2014 A | 1,101 | 0 | 0 | $0 |
| Bruce D Perkins | Sgmt Pres, Healthcare Services | Feb. 18, 2014 A | 15,946 | 0 | 0 | $0 |
| Paul B. K. Kusserow | Sr VP & Ch Strat Dev Officer | June 24, 2013 M | 19,347 | 0 | 0 | $0 |
| HATHCOCK BONNIE C | Sr VP & Chief Human Res. Off | Dec. 24, 2012 G | 2,287 | 0 | 0 | $0 |
| Venkata R Madabhushi | SVP & Chief Innov & Mrkting Of | April 28, 2012 F | 11,946 | 0 | 0 | $0 |
| GOODMAN BRUCE J | Sr. VP | Feb. 23, 2012 A | 23,280 | 0 | 0 | $0 |
| Jonathan T Lord MD | Sr VP & Chief Innovation Off. | Feb. 4, 2009 I | 0 | 0 | 0 | $0 |
| Arthur P Hipwell | Senior Vice President | March 27, 2008 J | 302 | 0 | 0 | $0 |
| Kathleen Pellegrino | VP and Acting General Counsel | Feb. 25, 2008 F | 13,836 | 0 | 0 | $0 |
| Steven O Moya | Sr. VP-Chief Marketing Officer | Dec. 31, 2007 I | 0 | 0 | 0 | $0 |
| John M Bertko | Vice President & Chief Actuary | Feb. 23, 2007 M | 57,548 | 0 | 0 | $0 |
| Eugene R Shields | Senior Vice President-Gov Prgm | Jan. 6, 2005 M | 0 | 0 | 0 | $0 |
| Kurt J Hilzinger | Director | June 30, 2026 A | 19,448 | 0 | 0 | $0 |
| Frank A Damelio | Director | Jan. 2, 2026 A | 20,634 | 0 | 0 | $0 |
| Karen Katz | Director | Dec. 31, 2025 A | 590 | 0 | 0 | $0 |
| David T Feinberg | Director | June 30, 2025 A | 441 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| David A. Jones ×2 filings | Nov. 12, 2003 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 199 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| FXH · First Trust Exchange-Traded AlphaDE… | 2.95% | 109,132 NS | April 30, 2026 | N-PORT |
| SMRI · EA Series Trust | 2.54% | 58,016 NS | April 30, 2026 | N-PORT |
| TGLB · T. Rowe Price Exchange-Traded Funds… | 2.26% | 2,111 NS | April 30, 2026 | N-PORT |
| SRHQ · Elevation Series Trust | 1.63% | 13,322 NS | April 30, 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 1.51% | 2,473 NS | April 30, 2026 | N-PORT |
| HWSM · HOTCHKIS & WILEY FUNDS /DE/ | 1.23% | 85 NS | June 30, 2026 | N-PORT |
| EPMV · Harbor ETF Trust | 1.20% | 225 NS | April 30, 2026 | N-PORT |
| ABCS · EA Series Trust | 1.19% | 441 NS | May 29, 2026 | N-PORT |
| MFSV · MFS Active Exchange Traded Funds Tr… | 1.14% | 17,702 NS | May 31, 2026 | N-PORT |
| NUMV · Nushares ETF Trust | 0.96% | 17,434 NS | April 30, 2026 | N-PORT |
| FTA · First Trust Exchange-Traded AlphaDE… | 0.95% | 52,223 NS | April 30, 2026 | N-PORT |
| ITAN · EA Series Trust | 0.77% | 2,259 NS | May 29, 2026 | N-PORT |
| CGMM · Capital Group Equity ETF Trust I | 0.72% | 65,925 NS | May 31, 2026 | N-PORT |
| AUSF · Global X Funds | 0.70% | 19,401 NS | May 31, 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.63% | 211 NS | May 31, 2026 | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 0.59% | 30,459 NS | April 30, 2026 | N-PORT |
| RXL · ProShares Trust | 0.53% | 1,258 NS | May 31, 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0.47% | 2,755 NS | April 30, 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.46% | 55,439 NS | April 30, 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0.45% | 28,340 NS | April 30, 2026 | N-PORT |
| DEUS · DBX ETF Trust | 0.43% | 3,849 NS | May 29, 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0.41% | 2,404 NS | April 30, 2026 | N-PORT |
| SPXD · DBX ETF Trust | 0.37% | 81 NS | May 31, 2026 | N-PORT |
| QARP · DBX ETF Trust | 0.36% | 887 NS | May 29, 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0.34% | 4,484 NS | May 31, 2026 | N-PORT |
| GMOV · GMO ETF Trust | 0.34% | 1,004 NS | May 31, 2026 | N-PORT |
| FNDX · SCHWAB STRATEGIC TRUST | 0.32% | 265,500 NS | May 31, 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0.29% | 12,439 NS | May 31, 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0.29% | 2,779 NS | April 30, 2026 | N-PORT |
| SPVU · Invesco Exchange-Traded Fund Trust … | 0.28% | 1,250 NS | May 31, 2026 | N-PORT |
| BRCE · MFS Active Exchange Traded Funds Tr… | 0.27% | 299 NS | May 31, 2026 | N-PORT |
| FFLC · FIDELITY COVINGTON TRUST | 0.26% | 12,272 NS | April 30, 2026 | N-PORT |
| GSEW · Goldman Sachs ETF Trust | 0.24% | 14,039 NS | May 31, 2026 | N-PORT |
| AFLG · First Trust Exchange-Traded Fund VI… | 0.21% | 4,491 NS | May 31, 2026 | N-PORT |
| FLCV · Federated Hermes ETF Trust | 0.20% | 634 NS | May 31, 2026 | N-PORT |
| FLCC · Federated Hermes ETF Trust | 0.18% | 708 NS | May 31, 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0.16% | 3,879 NS | April 30, 2026 | N-PORT |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0.15% | 4,555 NS | April 30, 2026 | N-PORT |
| HELO · J.P. Morgan Exchange-Traded Fund Tr… | 0.15% | 24,794 NS | April 30, 2026 | N-PORT |
| CATH · Global X Funds | 0.13% | 6,791 NS | April 30, 2026 | N-PORT |
| DFLV · Dimensional ETF Trust | 0.13% | 32,836 NS | April 30, 2026 | N-PORT |
| SCHG · SCHWAB STRATEGIC TRUST | 0.13% | 256,808 NS | May 31, 2026 | N-PORT |
| ACVF · ETF Opportunities Trust | 0.13% | 790 NS | April 30, 2026 | N-PORT |
| OALC · Unified Series Trust | 0.12% | 945 NS | May 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.12% | 10,240 NS | April 30, 2026 | N-PORT |
| GSLC · Goldman Sachs ETF Trust | 0.11% | 55,850 NS | May 31, 2026 | N-PORT |
| GVUS · Goldman Sachs ETF Trust | 0.11% | 1,461 NS | May 31, 2026 | N-PORT |
| USSG · DBX ETF Trust | 0.11% | 2,008 NS | May 29, 2026 | N-PORT |
| VEGN · ETF Series Solutions | 0.10% | 675 NS | April 30, 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.09% | 57,804 NS | April 30, 2026 | N-PORT |